ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹937 Cr | ₹556 Cr | ₹282 Cr | ₹358 Cr | ₹621 Cr |
What is the latest Total Non-Current Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹937 Cr |
| Mar2025 | ₹556 Cr |
| Mar2024 | ₹282 Cr |
| Mar2023 | ₹358 Cr |
| Mar2022 | ₹621 Cr |
How is Total Non-Current Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹937 Cr | 68.45 | |
| Mar2025 | ₹556 Cr | 96.98 | |
| Mar2024 | ₹282 Cr | -21.17 | |
| Mar2023 | ₹358 Cr | -42.35 | |
| Mar2022 | ₹621 Cr | - | |
Compare Total Non-Current Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,546.4 Cr | 1.1% | 10.7% | -10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 1.1% |
10.7% |
-10.9% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses